BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1588186)

  • 1. Molecular basis of invasive Haemophilus influenzae type b disease.
    Moxon ER
    J Infect Dis; 1992 Jun; 165 Suppl 1():S77-81. PubMed ID: 1588186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae.
    Moxon ER; Kroll JS
    Vaccine; 1988 Apr; 6(2):113-5. PubMed ID: 3291448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsule loss by Haemophilus influenzae type b results in enhanced adherence to and entry into human cells.
    St Geme JW; Falkow S
    J Infect Dis; 1992 Jun; 165 Suppl 1():S117-8. PubMed ID: 1350299
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis of meningitis: experimental studies on the molecular basis of Haemophilus influenzae infection.
    Moxon ER; Zwahlen A; Rubin LG; Hoiseth S; Connelly C
    Infection; 1984; 12 Suppl 1():S23-8. PubMed ID: 6241609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.
    Cope LD; Yogev R; Mertsola J; Argyle JC; McCracken GH; Hansen EJ
    Infect Immun; 1990 Jul; 58(7):2343-51. PubMed ID: 1694825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterisation of Haemophilus influenzae type a and untypeable strains isolated simultaneously from cerebrospinal fluid and blood: novel use of quantitative real-time PCR based on the cap copy number to determine virulence.
    Ohkusu K; Nash KA; Inderlied CB
    Clin Microbiol Infect; 2005 Aug; 11(8):637-43. PubMed ID: 16008616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digalactoside expression in the lipopolysaccharide of Haemophilus influenzae and its role in intravascular survival.
    Griffin R; Bayliss CD; Herbert MA; Cox AD; Makepeace K; Richards JC; Hood DW; Moxon ER
    Infect Immun; 2005 Oct; 73(10):7022-6. PubMed ID: 16177385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism.
    Moxon ER; Murphy PA
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1534-6. PubMed ID: 306628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase variation of lic1A, lic2A and lic3A in colonization of the nasopharynx, bloodstream and cerebrospinal fluid by Haemophilus influenzae type b.
    Hosking SL; Craig JE; High NJ
    Microbiology (Reading); 1999 Nov; 145 ( Pt 11)():3005-3011. PubMed ID: 10589708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae.
    Weiser JN; Williams A; Moxon ER
    Infect Immun; 1990 Oct; 58(10):3455-7. PubMed ID: 2401571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of capsular genes in Haemophilus influenzae isolates from H. influenzae type b vaccine recipients.
    Falla TJ; Crook DW; Anderson EC; Ward JI; Santosham M; Eskola J; Moxon ER
    J Infect Dis; 1995 Apr; 171(4):1075-6. PubMed ID: 7706799
    [No Abstract]   [Full Text] [Related]  

  • 12. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants.
    Moxon ER; Vaughn KA
    J Infect Dis; 1981 Apr; 143(4):517-24. PubMed ID: 6972419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap.
    Zwahlen A; Kroll JS; Rubin LG; Moxon ER
    Microb Pathog; 1989 Sep; 7(3):225-35. PubMed ID: 2615636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PCR-based capsular typing of Haemophilus influenzae isolates non-typeable by agglutination].
    Weltman G; Fossati MS; Correa C; Regueira M; Mollerach M
    Rev Argent Microbiol; 2005; 37(4):199-202. PubMed ID: 16502640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats.
    Zwahlen A; Rubin LG; Moxon ER
    Microb Pathog; 1986 Oct; 1(5):465-73. PubMed ID: 3509884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the cell wall of Haemophilus influenzae type b by transformation with cloned DNA: association with attenuated virulence.
    Zwahlen A; Rubin LG; Connelly CJ; Inzana TJ; Moxon ER
    J Infect Dis; 1985 Sep; 152(3):485-92. PubMed ID: 3875666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A virulent nonencapsulated Haemophilus influenzae.
    Nizet V; Colina KF; Almquist JR; Rubens CE; Smith AL
    J Infect Dis; 1996 Jan; 173(1):180-6. PubMed ID: 8537657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae serotype a as a cause of serious invasive infections.
    Ulanova M; Tsang RSW
    Lancet Infect Dis; 2014 Jan; 14(1):70-82. PubMed ID: 24268829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nontypeable Haemophilus influenzae strains with the capsule-associated insertion element IS1016 may mimic encapsulated strains.
    Karlsson E; Melhus A
    APMIS; 2006 Sep; 114(9):633-40. PubMed ID: 16948816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric orbital cellulitis in the Haemophilus influenzae vaccine era.
    Sharma A; Liu ES; Le TD; Adatia FA; Buncic JR; Blaser S; Richardson S
    J AAPOS; 2015 Jun; 19(3):206-10. PubMed ID: 25900771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.